EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Fever management with or without a temperature control device after out‐of‐hospital cardiac arrest and resuscitation ( TEMP ‐ CARE ): A study protocol for a randomized clinical trial

Fiebermanagement mit oder ohne Temperaturkontrollgerät nach außerklinischem Herz-Kreislauf-Stillstand und Reanimation (TEMP-CARE): Studienprotokoll für eine randomisierte klinische Studie

Johan Holgersson, V Niemelä iD, M B Skrifvars iD, C Kamp-Jorgensen, M Saxena, P Young, F Bass, J Dankiewicz, N Hammond, J Hästbacka, H Levin, G Lilja und 48 weitere

Acta Anaesthesiologica Scandinavica · 2025-05 · 69 (5)

DOI: 10.1111/aas.70034 ↗

Auf einen Blick

TEMP-CARE untersucht nach außerklinischem Herz-Kreislauf-Stillstand, ob Fiebermanagement mit einem feedback-gesteuerten Temperaturkontrollgerät patientenrelevante Outcomes beeinflusst. Primärer Endpunkt ist die Mortalität nach 6 Monaten.

Fragestellung

Wirkt Fiebermanagement mit einem Temperaturkontrollgerät im Vergleich zu Fiebermanagement ohne Gerät nach außerklinischem Herz-Kreislauf-Stillstand auf patientenrelevante Outcomes?

Methode

Randomisierte, internationale, multizentrische, parallele, vom Prüfer initiierte Superiority-Studie; Teil der 2 × 2 × 2-Faktorstudie STEPCARE. Zufall zu Fiebermanagement mit oder ohne feedback-gesteuertes Gerät.

Ergebnisse

Bei Temperatur ≥37,8 °C innerhalb von 72 h nach Randomisierung wird das Gerät mit Ziel ≤37,5 °C gestartet. Primärer Endpunkt ist die Gesamtmortalität nach 6 Monaten; sekundär u. a. schlechtes funktionelles Outcome und schwere UAW.

Schlussfolgerung der Autor:innen

Die TEMP-CARE-Studie wird untersuchen, ob das Fiebermanagement nach Herz-Kreislauf-Stillstand mit oder ohne Temperaturkontrollgerät patientenrelevante Outcomes beeinflusst.

Kernaussagen

  • Studienprotokoll, keine Ergebnisse berichtet
  • Randomisierung zu Fiebermanagement mit oder ohne Gerät
  • Primärer Endpunkt: Mortalität nach 6 Monaten

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 13.04.2025. Verfasst von Johan Holgersson und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Lund, Anesthesia and Intensive Care, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Cardiopulmonary Resuscitation, Fever, Hypothermia, Induced, Out-of-Hospital Cardiac Arrest. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, ALF-project funding within the Swedish Health Care, Academy of Finland.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fever is associated with brain injury after cardiac arrest. It is unknown whether fever management with a feedback‐controlled device impacts patient‐centered outcomes in cardiac arrest patients. This trial aims to investigate fever management with or without a temperature control device after out‐of‐hospital cardiac arrest.

Methods

The TEMP‐CARE trial is part of the 2 × 2 × 2 factorial Sedation, TEmperature and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, a randomized, international, multicenter, parallel‐group, investigator‐initiated, superiority trial that will evaluate sedation strategies, temperature management, and blood pressure targets simultaneously in nontraumatic/nonhemorrhagic out‐of‐hospital cardiac arrest patients following hospital admission. For the temperature management component of the trial described in this protocol, patients will be randomly allocated to fever management with or without a feedback‐controlled temperature control device. For those managed with a device, if temperature ≥37.8°C occurs within 72 h post‐randomization the device will be started targeting a temperature of ≤37.5°C. Standard fever treatment, as recommended by local guidelines, including pharmacological agents, will be provided to participants in both groups. The two other components of the STEPCARE trial evaluate sedation and blood pressure strategies. Apart from the STEPCARE trial interventions, all other aspects of general intensive care will be according to the local practices of the participating site. A physician blinded to the intervention will determine the neurological prognosis following European Resuscitation Council and European Society of Intensive Care Medicine guidelines. The primary outcome is all‐cause mortality at six months post‐randomization. To detect a 5.6% absolute risk reduction (90% power, alpha .05), 3500 participants will be enrolled. Secondary outcomes include poor functional outcome at six months, intensive care‐related serious adverse events, and overall health status at six months.

Conclusion

The TEMP‐CARE trial will investigate if post‐cardiac arrest management of fever with or without a temperature control device affects patient‐important outcomes after cardiac arrest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiopulmonary ResuscitationFeverHypothermia, InducedOut-of-Hospital Cardiac ArrestHumansBody TemperatureRandomized Controlled Trials as TopicMulticenter Studies as TopicEquivalence Trials as Topic

Stichwörter der Autor:innen

cardiac arrestfeedback‐controlled devicefeverrandomized controlled trialtemperature management

Autor:innen und Institutionen

  • Department of Clinical Sciences Lund, Anesthesia and Intensive Care, Lund University, Lund, Sweden.
  • Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden.
  • Department of Anaesthesia and Intensive Care, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Critical Care Division and Department of Intensive Care Medicine, The George Institute for Global Health and St George Hospital Clinical School, University of New South Wales, Sydney, Australia.

ORCID-Profile: V Niemelä, M B Skrifvars, A Ceric, A Lybeck, A Lundin, P Druwé, D Wyncoll, J White, M Iten, M Nafi, M Joannidis

Förderung

  • Swedish Research Council
  • ALF-project funding within the Swedish Health Care
  • Academy of Finland
  • Sigrid Jusélius Foundation (Finland)
  • Hospital district of Helsinki and Uusimaa (Finland)
  • Medicinska Understödsföreningen Liv och Hälsa (Sweden)
  • Medical Research Future Fund (Australia)
  • Health Research Council of New Zealand, and the Clinical Research Programme Directorate of Health Ministry of Health and Social Security (Luxembourg)

Zitieren

APA

Holgersson, J., Niemelä, V., Skrifvars, M. B., Kamp-Jorgensen, C., Saxena, M., Young, P., Bass, F., Dankiewicz, J., Hammond, N., Hästbacka, J., Levin, H., Lilja, G., Moseby-Knappe, M., Tiainen, M., Reinikainen, M., Ceric, A., Düring, J., Lybeck, A., Rodriguez-Santos, D., …, & Belohlavek, J. (2025). Fever management with or without a temperature control device after out‐of‐hospital cardiac arrest and resuscitation ( TEMP ‐ CARE ): A study protocol for a randomized clinical trial. Acta Anaesthesiologica Scandinavica, 69(5). https://doi.org/10.1111/aas.70034

Vancouver

Holgersson J, Niemelä V, Skrifvars MB, Kamp-Jorgensen C, Saxena M, Young P, et al. Fever management with or without a temperature control device after out‐of‐hospital cardiac arrest and resuscitation ( TEMP ‐ CARE ): A study protocol for a randomized clinical trial. Acta Anaesthesiologica Scandinavica. 2025;69(5). doi:10.1111/aas.70034

BibTeX
@article{Holgersson2025,
  author = {Holgersson, Johan and Niemelä, V and Skrifvars, M B and Kamp-Jorgensen, C and Saxena, M and Young, P and Bass, F and Dankiewicz, J and Hammond, N and Hästbacka, J and Levin, H and Lilja, G and Moseby-Knappe, M and Tiainen, M and Reinikainen, M and Ceric, A and Düring, J and Lybeck, A and Rodriguez-Santos, D and Johnsson, J and Unden, J and Lundin, A and Kåhlin, J and Grip, J and Rosell, J and Lotman, E M and Navarra, L and Crichton, B and Knight, D and Williams, A and Romundstad, L and Seidel, P and Stammet, P and Graf, T and Mengel, A and Leithner, C and Nee, J and Druwé, P and Ameloot, K and Wise, M and Riddel, J and Ahmed, M and Buckel, M and Mc Guigan, P and Maharaj, R and Wyncoll, D and Thomas, M and White, J and Keeble, T R and Pogson, D and Nichol, A and Haenggi, M and Hilty, M P and Iten, M and Schrag, C and Nafi, M and Joannidis, M and Robba, C and Pellis, T and Belohlavek, J},
  title = {Fever management with or without a temperature control device after out‐of‐hospital cardiac arrest and resuscitation ( TEMP ‐ CARE ): A study protocol for a randomized clinical trial},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2025},
  volume = {69},
  number = {5},
  doi = {10.1111/aas.70034}
}
Kostenlos starten →